Spots Global Cancer Trial Database for LifePearl-Iri Pharmacokinetic Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: LifePearl-Iri Pharmacokinetic Study
Official Title: Pharmacokinetic Study In Patients With Liver Predominant Unresectable mCRC Receiving Treatment With LifePearl Microspheres Loaded With Irinotecan
Study ID: NCT02547480
Interventions
Study Description
Brief Summary: The primary purpose of the study is to evaluate the pharmacokinetic profile, safety, and efficacy of LifePearl microspheres loaded with irinotecan in the treatment of liver predominant mCRC by chemoembolization.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
KUL, Leuven, , Belgium
SLK-Kliniken Heilbronn GmbH, Heilbronn, , Germany
Klinikum Bogenhausen, Städt. Klinikum München GmbH, Munich, , Germany
Contact Details
Name: Hans Prenen, MD
Affiliation: Universitair Ziekenhuis Leuven
Role: PRINCIPAL_INVESTIGATOR
Name: Philippe Pereira, MD
Affiliation: SLK Kliniken Heilbronn GmbH
Role: PRINCIPAL_INVESTIGATOR
Name: Julien Taieb, MD
Affiliation: Hôpital Georges Pompidou Paris
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
